LY 255283
Alternative Names: CGS 23356; LY 177455Latest Information Update: 08 Nov 1994
At a glance
- Originator Eli Lilly and Company
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Small molecules; Tetrazoles
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma